EDOC:NSD-Global X Telemedicine & Digital Health ETF (USD)

ETF | Others |

Last Closing

USD 10.36

Change

-0.07 (-0.67)%

Market Cap

USD 0.04B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+2.05 (+4.15%)

USD 59.02B
QQQM Invesco NASDAQ 100 ETF

+2.62 (+1.28%)

USD 42.88B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.67 (+1.24%)

USD 22.89B
ACWI iShares MSCI ACWI ETF

+1.88 (+1.58%)

USD 19.98B
CGABL The Carlyle Group Inc. 4.625% ..

+0.05 (+0.28%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

+1.02 (+2.33%)

USD 4.90B
TBIL Rbb Fund Inc - Us Treasury 3 M..

-0.01 (-0.02%)

USD 4.81B
TSLL Direxion Shares ETF Trust - Di..

+0.60 (+5.20%)

USD 4.32B
ETHA iShares Ethereum Trust ETF

+0.71 (+4.38%)

USD 3.75B
USCL iShares Climate Conscious & Tr..

+0.84 (+1.21%)

USD 2.33B

ETFs Containing EDOC

HDOC:CA 98.44 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.39% 84% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.39% 84% B 79% B-
Trailing 12 Months  
Capital Gain 11.52% 79% B- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.52% 77% C+ 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -13.60% 11% F 18% F
Dividend Return -13.60% 10% F 17% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.13% 38% F 82% B
Risk Adjusted Return -84.35% 4% F 6% D-
Market Capitalization 0.04B 54% F 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.